Increased diversity of a cervical microbiome associates with cervical cancer

From BugSigDB
Needs review
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Zeber-Lubecka N, Kulecka M, Lindner B, Krynicki R, Paziewska A, Nowakowski A, Bidzinski M, Ostrowski J
Journal
Frontiers in oncology
Year
2022
Keywords:
16S rRNA gene sequencing, cervical microbiome, chemoradiation therapy, lactobacillus, postmenopause
The cervical microbiome (CM) is a complex ecosystem that can change in response to gynecological cancers. We aimed to evaluate changes in the CM of patients who underwent chemoradiation (CRT) therapy for locally advanced cervical cancer. Before and after CRT, cervical swab samples were collected from 16 patients with squamous cell carcinoma of the cervix, and 30 healthy women. All samples were subjected to 16s rRNA-Seq analysis. In healthy premenopausal women the CM comprised mostly Lactobacillus (>90%); the CM community in samples from both pre- and postmenopausal pre-treatment cancer patients was heterogeneous, with a low proportion of Lactobacillus in younger cases. On the genus level, 27 and 11 taxa differentiated healthy controls from cancer patients in pre- and postmenopausal age groups, while 31 and 2 genera differentiated pre- and post-radiation samples and pre-radiation and the follow-up samples, respectively. Microbiome diversity was significantly higher in pre-treatment patients than in healthy controls. The results reveal significant alterations in the CM of cervical cancer patients relative to that in healthy controls; these changes were more striking after CRT. However, further research is needed to determine whether alteration of the CM offers new therapeutic options.

Experiment 1


Needs review

Curated date: 2024/04/26

Curator: Joan Chuks

Revision editor(s): Joan Chuks, Victoria

Subjects

Location of subjects
Poland
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Uterine cervix Canalis cervicis uteri,Caudal segment of uterus,Cervical canal,Cervical canal of uterus,Cervix,Cervix of uterus,Cervix uteri,Neck of uterus,Uterine cervix,uterine cervix
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Response to radiation Response to radiation,response to radiation
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Premenopausal healthy controls (HPV Negative women)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Premenopausal Pre-treatment group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women, aged 25–54 years, with squamous cell carcinoma of the cervix who were indicated for primary Radiation therapy(RT), and their samples collected a day before starting external beam radiation therapy (EBRT).
Group 0 sample size Number of subjects in the control (unexposed) group
15
Group 1 sample size Number of subjects in the case (exposed) group
6
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
2 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V2-V9
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Ion Torrent

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
centered log-ratio
Statistical test
ANCOM
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
unchanged

Signature 1

Needs review

Curated date: 2024/04/27

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Table 2

Description: Differential bacterial abundance in the cervical microbiome between premenopausal healthy controls (HPV Negative women) and premenopausal women with squamous cell carcinoma of the cervix, before starting external beam radiation therapy (EBRT), as determined by ANCOM-BC Analysis.

Abundance in Group 1: increased abundance in Premenopausal Pre-treatment group

NCBI Quality ControlLinks
Anaerococcus
Atopobium
Bulleidia
Campylobacter
Dialister
Fastidiosipila
Fenollaria
Fusobacterium
Gemella
Mobiluncus
Moryella
Parvimonas
Peptococcus
Peptoniphilus
Peptostreptococcus
Porphyromonas
Prevotella
Solobacterium
Stomatobaculum

Revision editor(s): Joan Chuks

Signature 2

Needs review

Curated date: 2024/04/27

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Table 2

Description: Differential bacterial abundance in the cervical microbiome between premenopausal healthy controls (HPV Negative women) and premenopausal women with squamous cell carcinoma of the cervix, before starting external beam radiation therapy (EBRT), as determined by ANCOM-BC Analysis.

Abundance in Group 1: decreased abundance in Premenopausal Pre-treatment group

NCBI Quality ControlLinks
Acinetobacter
Aminobacter
Cutibacterium
Escherichia/Shigella sp.
Lactobacillus
Pseudomonas
Rheinheimera
Staphylococcus

Revision editor(s): Joan Chuks

Experiment 2


Needs review

Curated date: 2024/04/28

Curator: Joan Chuks

Revision editor(s): Joan Chuks, Victoria

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Postmenopausal healthy controls (HPV Negative women)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Postmenopausal Pre-treatment group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women, aged 54–62 years, with squamous cell carcinoma of the cervix who were indicated for primary Radiation therapy(RT), and their samples collected a day before starting external beam radiation therapy (EBRT).
Group 1 sample size Number of subjects in the case (exposed) group
10

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
unchanged

Signature 1

Needs review

Curated date: 2024/04/28

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Table 2

Description: Differential bacterial abundance in the cervical microbiome between postmenopausal healthy controls (HPV Negative women) and postmenopausal women with squamous cell carcinoma of the cervix, before starting external beam radiation therapy (EBRT), as determined by ANCOM-BC Analysis.

Abundance in Group 1: increased abundance in Postmenopausal Pre-treatment group

NCBI Quality ControlLinks
Arcanobacterium
Fusobacterium
Moryella
Peptococcus
Peptoniphilus
Porphyromonas
Stomatobaculum

Revision editor(s): Joan Chuks

Signature 2

Needs review

Curated date: 2024/04/28

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Table 2

Description: Differential bacterial abundance in the cervical microbiome between postmenopausal healthy controls (HPV Negative women) and postmenopausal women with squamous cell carcinoma of the cervix, before starting external beam radiation therapy (EBRT), as determined by ANCOM-BC Analysis.

Abundance in Group 1: decreased abundance in Postmenopausal Pre-treatment group

NCBI Quality ControlLinks
Gardnerella
Gemella
Lentilitoribacter
Mesorhizobium

Revision editor(s): Joan Chuks

Experiment 3


Needs review

Curated date: 2024/04/28

Curator: Joan Chuks

Revision editor(s): Joan Chuks, Victoria

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Premenopausal healthy controls (HPV Negative women)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Premenopausal Post-treatment group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women, aged 25–54 years, with squamous cell carcinoma of the cervix who were indicated for primary Radiation therapy(RT), and their samples collected immediately after the last fraction of brachytherapy (ICBT) was given.
Group 1 sample size Number of subjects in the case (exposed) group
6

Lab analysis

Statistical Analysis

Signature 1

Needs review

Curated date: 2024/04/28

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Supplementary Table S2

Description: Differential bacterial abundance in the cervical microbiome between premenopausal healthy controls (HPV Negative women) and premenopausal women with squamous cell carcinoma of the cervix, immediately after the last fraction of brachytherapy (ICBT) was given, as determined by ANCOM-BC Analysis.

Abundance in Group 1: increased abundance in Premenopausal Post-treatment group

NCBI Quality ControlLinks
Anaerococcus
Campylobacter
Clostridiales bacterium S5-A14a
Corynebacterium
Dialister
Finegoldia
Peptoniphilus
Peptostreptococcus
Prevotella
Streptococcus

Revision editor(s): Joan Chuks

Signature 2

Needs review

Curated date: 2024/04/28

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Supplementary Table S2

Description: Differential bacterial abundance in the cervical microbiome between premenopausal healthy controls (HPV Negative women) and premenopausal women with squamous cell carcinoma of the cervix, immediately after the last fraction of brachytherapy (ICBT) was given, as determined by ANCOM-BC Analysis.

Abundance in Group 1: decreased abundance in Premenopausal Post-treatment group

NCBI Quality ControlLinks
Aminobacter
Bifidobacterium
Brucella
Granulicatella
Hoeflea
Ottowia
Parabacteroides
Pluralibacter

Revision editor(s): Joan Chuks

Experiment 4


Needs review

Curated date: 2024/04/29

Curator: Joan Chuks

Revision editor(s): Joan Chuks, Victoria

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Postmenopausal healthy controls (HPV Negative women)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Postmenopausal Post-treatment group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women, aged 54–62 years, with squamous cell carcinoma of the cervix who were indicated for primary Radiation therapy(RT), and their samples collected immediately after the last fraction of brachytherapy (ICBT) was given.
Group 1 sample size Number of subjects in the case (exposed) group
10

Lab analysis

Statistical Analysis

Signature 1

Needs review

Curated date: 2024/04/29

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Supplementary Table S2

Description: Differential bacterial abundance in the cervical microbiome between postmenopausal healthy controls (HPV Negative women) and postmenopausal women with squamous cell carcinoma of the cervix, immediately after the last fraction of brachytherapy (ICBT) was given, as determined by ANCOM-BC Analysis.

Abundance in Group 1: increased abundance in Postmenopausal Post-treatment group

NCBI Quality ControlLinks
Caulobacter
Diaphorobacter
Porphyromonas
Methylobacterium-MethylorubrumMethylobacterium-Methylorubrum

Revision editor(s): Joan Chuks

Signature 2

Needs review

Curated date: 2024/04/29

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Supplementary Table S2

Description: Differential bacterial abundance in the cervical microbiome between postmenopausal healthy controls (HPV Negative women) and postmenopausal women with squamous cell carcinoma of the cervix, immediately after the last fraction of brachytherapy (ICBT) was given, as determined by ANCOM-BC Analysis.

Abundance in Group 1: decreased abundance in Postmenopausal Post-treatment group

NCBI Quality ControlLinks
Gardnerella
Lentilitoribacter
Mesorhizobium

Revision editor(s): Joan Chuks

Experiment 5


Needs review

Curated date: 2024/04/29

Curator: Joan Chuks

Revision editor(s): Joan Chuks, Victoria

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Pre-treatment group
Group 1 name Corresponds to the case (exposed) group for case-control studies
Post-treatment group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women with squamous cell carcinoma of the cervix who were indicated for primary Radiation therapy(RT), and their samples collected immediately after the last fraction of brachytherapy (ICBT) was given.
Group 1 sample size Number of subjects in the case (exposed) group
15

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged

Signature 1

Needs review

Curated date: 2024/04/29

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Table 3

Description: Differential bacterial abundance in the cervical microbiome of women with squamous cell carcinoma of the cervix, before starting the external beam radiation therapy (EBRT) compared to immediately after the last fraction of brachytherapy (ICBT) was given, as determined by ANCOM-BC Analysis

Abundance in Group 1: increased abundance in Post-treatment group

NCBI Quality ControlLinks
Acinetobacter
Blautia
Caulobacter
Cloacibacterium
Corynebacterium
Cupriavidus
Cutibacterium
Diaphorobacter
Finegoldia
Lactococcus
Massilia
Muribaculum
Neisseria
Pedobacter
Pseudomonas
Ralstonia
Renibacterium
Rheinheimera
Roseateles
Staphylococcus
Streptococcus
Methylobacterium- MethylorubrumMethylobacterium- Methylorubrum

Revision editor(s): Joan Chuks

Signature 2

Needs review

Curated date: 2024/04/29

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Table 3

Description: Differential bacterial abundance in the cervical microbiome of women with squamous cell carcinoma of the cervix, before starting the external beam radiation therapy (EBRT) compared to immediately after the last fraction of brachytherapy (ICBT) was given, as determined by ANCOM-BC Analysis

Abundance in Group 1: decreased abundance in Post-treatment group

NCBI Quality ControlLinks
Bulleidia
Fusobacterium
Olsenella
Peptococcus
Porphyromonas
Prevotella
Solobacterium
Stomatobaculum

Revision editor(s): Joan Chuks

Experiment 6


Needs review

Curated date: 2024/04/29

Curator: Joan Chuks

Revision editor(s): Joan Chuks, Victoria

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
3-months post treatment group (follow-up samples)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women with squamous cell carcinoma of the cervix who were indicated for primary Radiation therapy(RT), 3 months after the last fraction of brachytherapy (ICBT) was given.
Group 1 sample size Number of subjects in the case (exposed) group
9

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged

Signature 1

Needs review

Curated date: 2024/04/29

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Table 3

Description: Differential bacterial abundance in the cervical microbiome of women with squamous cell carcinoma of the cervix, before starting the external beam radiation therapy (EBRT) compared to 3-months after the last fraction of brachytherapy (ICBT) was given, as determined by ANCOM-BC Analysis

Abundance in Group 1: increased abundance in 3-months post treatment group (follow-up samples)

NCBI Quality ControlLinks
Finegoldia

Revision editor(s): Joan Chuks

Signature 2

Needs review

Curated date: 2024/04/29

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Table 3

Description: Differential bacterial abundance in the cervical microbiome of women with squamous cell carcinoma of the cervix, before starting the external beam radiation therapy (EBRT), compared to 3-months after the last fraction of brachytherapy (ICBT) was given, as determined by ANCOM-BC Analysis

Abundance in Group 1: decreased abundance in 3-months post treatment group (follow-up samples)

NCBI Quality ControlLinks
Solobacterium

Revision editor(s): Joan Chuks